Health
Looking beyond COVID-19’s spike protein for the next wave of vaccines – FierceBiotech
Most ongoing vaccine development efforts against the novel coronavirus focus on the spike protein on the surface of SARS-CoV-2. But a team led by immuno-oncology specialist TScan Therapeutics found that memory CD8+ T cells from recovered patients mainly targe…
Most ongoing vaccine development efforts against the novel coronavirus use the spike protein on the surface of SARS-CoV-2 in the hopes of inducing neutralizing antibodies that can directly block the virus from infecting healthy cells. But there could be one major caveat to that approach: The antibody response to the virus, mediated by B cells of the immune system, appears to wane quickly.
Thats why a research team led by immuno-oncology biotech TScan Therapeutics turned to another key component…
-
General24 hours agoPort’s lease a ‘mistake’ as major parties flag takeover
-
Business22 hours agoThese ASX 200 shares could rise 50% to 60%
-
General22 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News23 hours agoQueensland’s film boom: How the Sunshine State is cementing its place as Hollywood’s favourite